Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-06-18

Virus-like particles: the next step in gene therapy

Objective

Virus–like protein particles can be applied as carriers for RNA gene therapy. The release of the RNA, however, is still a major problem. The goal of this proposal is to develop new routes towards the controlled opening of the virus capsid combining the cutting-edge science of bioconjugate chemistry and virology. This project intends to find a suitable carrier among non-infectious virus particles for small interfering RNA (siRNA) to be used for gene therapy. siRNA has the ability to specifically degrade RNA of a particular sequence and selectively stop the production of an abnormal undesired protein, which makes it a very promising therapeutic agent. The major obstacle, however, is to find an efficient method for cellular delivery of the RNA material. Virus-like particles, that are self-assembled protein cages, have the potential to be used as addressable carriers for siRNA. The Finn Group at the Scripps Research Institute has recently developed a method to produce virus-like particles that contain siRNA. The goal of the project is to engineer this particle, such that it successfully delivers the RNA into the targeted cell. This project will have the potential to make significant contributions to the fields of biomedicine and targeted drug delivery, strategically important areas identified by the European Technology Platform on Nanomedicine.

Call for proposal

FP7-PEOPLE-2009-IOF
See other projects for this call

Coordinator

TECHNISCHE UNIVERSITEIT EINDHOVEN
EU contribution
€ 237 911,80
Address
GROENE LOPER 3
5612 AE Eindhoven
Netherlands

See on map

Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Egbert Willem Meijer (Prof.)
Links
Total cost
No data